check_circleStudy Completed

Atopic dermatitis

Bayer Identifier:

1400401

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Dermatology I

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

2 - 15 Years
  • -

  • -

Trial summary

Enrollment Goal
265
Trial Dates
March 2005 - August 2005
Phase
Phase 4
Could I Receive a placebo
N/A
Products
Advantan (Methylprednisolone Aceponate, BAY86-4862)
Accepts Healthy Volunteer
N/A

Trial design

Double-blind, randomized, reference-controlled, multicenter, parallel-group study to compare the efficacy and safety of Advantan ointment once daily with Protopic 0.03% ointment twice daily over max. 3 weeks in 250 children and adolescents with atopic dermatitis
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.